Autologous bone marrow stem cells transplantation for liver cirrhosis

Status

Recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-12001892

Enrollment

Unknown

Registered

2012-01-17

Start date

2010-09-07

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

group A:conventional therapy+antiviral therapy

group B:stem cells+conventional therapy +antiviral therapy

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. to be diagnosed post-hepatitis B cirrhosis; 2. Child-Pugh B and C; 3. Aged 18-70 years old; 4. Signe informed consent.

Exclusion criteria

Exclusion criteria: 1. Diagnosed cirrhosis for other reasons; 2. Malignant tumor; 3. cardiac insufficiency; 4. renal insufficiency; 5. Allergy to vascular contrast agent; 6. Combined esophageal and gastric variceal bleeding, infection and hepatic encephalopathy; 7. portal vein thrombosis.

Design outcomes

Primary

Measure	Time frame
serum albumin;serum total bilirubin;prothrombin time;ascites;Hepatic encephalopathy;live time;alpha-fetoprotei;	—

Secondary

Measure	Time frame
HBV DNA copies;	—

Countries

China

Contacts

Public ContactMaotao HUANG

huangmt2003@yahoo.com.cn+86 13547887909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026